(9.4%) were abnormal during the first week and 68 (10-5%) had an increased PEF variability during the second week, but only 24 (3.7%) children had an increased PEF variability in both weeks. The sensitivity (specificity) for doctordiagnosed asthma (12 month period prevalence) was 36-4% (91-0%) in the first week of the second survey. When measurements of both weeks of the second survey were used to calculate PEF variability there was little improvement in the sensitivity (38-1%) and specificity (91-5%), mainly because of decreased compliance in the second measurement week. Conclusions -In young children assessment of PEF variability in order to screen for asthma is of limited value because of the low reproducibility of the method.
Background -Variability of peak expiratory flow (PEF) has been proposed as a surrogate for bronchial hyperresponsiveness. The normal range ofvariability of PEF for children has been reported and the test has been used to screen for asthma in population based studies. However, there is little information on the reproducibility of the method in epidemiological settings. Methods -In a cohort study of primary school children the variability in PEF was recorded in two consecutive years for one week (first survey) and two weeks (second survey) using mini Conflicting evidence has been published regarding the sensitivity and specificity of PEF variability in detecting asthma.3512 The rationale on which its value as an asthma screening test is based is the close association between PEF variability and nonspecific bronchial hyperreponsiveness as measured by histamine challenge. '2 We have observed that variability in PEF has a low sensitivity for doctor-diagnosed asthma in young children. '5 We therefore hypothesised that a measurement period of one week, as used in our study, might have been too short and this may have been the main reason for our findings. The study was therefore repeated within the same cohort of children after one year and the observation period was extended to two weeks. The purpose of this report is to describe the long term variability (year to year) as well as the short term variability (week to week) of the measurement. Sensitivity and specificity of the one week protocol was compared with a two week protocol for a diagnosis of asthma.
Methods

DESIGN AND TIME SCHEDULE
This analysis is based upon data from a cohort study on the development of asthma and allergy University Children's Hospital, Waehringerguertel in primary school children. Data collection took place between March 1990 and March 1993 at three locations in south-western Germany. The study aimed at investigating both genetic and environmental risk factors for the development of asthma, allergy, and bronchial hyperresponsiveness. Ethical approval was sought by the University of Freiburg and informed consent was obtained from the parents before all measurements. A detailed description of the study design is provided elsewhere. '6 Briefly, parental questionnaires were distributed in the spring of each school year. The questionnaire was tested for validity and repeatability in a separate study. '6 Home visits were performed between December and April in 1990-1 and 1991-2. Amongst other measurements (interview, dust sampling, urine collection) PEF recordings were performed using mini Wright peak flow meters in both years. In the spring of each study year skin prick tests were performed in order to define the atopic status of the children.
QUESTIONNAIRE
The 12 month period prevalence of asthma and recurrent wheezy bronchitis (defined as a doctor diagnosis) were recorded. A history of respiratory symptoms was also taken at each survey. For this report the 12 month period prevalences of respiratory symptoms recorded in the second (1991), third (1992), and fourth (1993) questionnaires were used for analysis in order to cover the time periods when PEF measurements had taken place. Cough after exercise was defined as an affirmative answer to "Did your child cough frequently after exercise or when exposed to cold air or fog in the last 12 months?" and wheeze as an affirmative answer to "In the last 12 months have you heard a whistling or wheezing noise in your child's breathing?" Morning cough was defined by the question "Did your child have a cough or shortness ofbreath at night or in the morning in the last 12 months?" A positive answer to "Did your child have attacks of shortness of breath or breathlessness in the last 12 months?" was taken to suggest dyspnoea.
VARIABILITY IN PEF
First survey (1990-1) Children and their parents were instructed in the correct use of the mini Wright peak flow meter. Children were familiar with the use of the peak flow meter because an exercise test had taken place earlier in the study in which PEF recordings were performed. Parents were asked to record the best of three readings their child achieved twice daily (07.00-09.00 hours and 16.00-19.00 hours) and tests were performed while standing. Measurements were recorded on a specially designed sheet on which the verbal instructions were reinforced. The importance of adhering to the time at which measurements should be taken was emphasised and parents were encouraged to insert blanks rather than inaccurate data. Peak flow meters were collected after one week and sheets checked for plausibility of data. Current respiratory illness was defined as cough on more than two days during the study week.
Second survey (1991-2) Home visits were repeated, including the same measurements as the year before. The same protocol and equipment were used for the collection of PEF data, but the observation period was extended to 14 days.
SKIN PRICK TEST
A standardised skin prick test using seven common allergens (birch, grass and hazel pollen, cat and dog dander, Dermatophagoides pteronyssinus and Dfarinae (ALK Laboratories, Denmark)), a positive (histamine 10 mg/ml) and a negative (NaCl) control was performed on the right forearm ofall children. The smallest and largest diameter of every weal was measured after 15 minutes and the arithmetic mean calculated. Sensitisation to a specific allergen was assumed when the allergen/histamine ratio was 05 and the allergen weal was at least 2 mm in diameter.'7 Children with at least one positive reaction to any of the allergens were designated as being atopic. The skin prick test was repeated at the second and third survey. For this analysis a child's atopic status was defined on the basis of the first and second skin prick test. A child was considered to be atopic when either test was positive. DATA 
ANALYSIS
As an index of PEF variability the ratio of amplitude/mean of daily PEF expressed as a percentage (amplitude/mean as a percentage = (higher value -lower value)/mean x 100) was calculated for each day. Diurnal variability of PEF was calculated as the average amplitude/ mean as a percentage for the observation time for those children who had measured their PEF twice daily for at least five days at the first survey. At the second survey PEF variability was calculated in the same manner but for the two measurement weeks separately. A further measure of PEF variability was derived using the PEF data from both weeks at the second survey for children with at least 10 days of complete data. (table  1) . The 12 month period prevalence of asthma was 1 3% at the first survey and 1-2% at the second survey. A diagnosis of recurrent wheezy bronchitis was recorded in 2-0% of children in the first survey and 2-5% in the second survey.
The Spearman correlation coefficient for average amplitude as a percentage of mean between the first and the second week of the second survey was 0A49 (p<0001; fig 1) for all participants, 0-34 (p<0 05) for children with asthma at either survey, and 0-5 (p<0 001) for children with respiratory symptoms suggestive ofasthma (at least one offour respiratory symptoms) at either survey. The association improved marginally when children with respiratory symptoms during the study period were excluded (r = 0-53; p<0001). In order to investigate whether this finding is due to a low correlation in children with low PEF variability, values of average amplitude as a percentage of mean of the first study week were divided into quartiles and quartile specific correlations were calculated, but these did not explain the low correlation (lst quartile: r = 0-28, 2nd quartile: r = 0-13, 3rd quartile: r = 0 15; 4th quartile: r = 04). Of 646 children who performed five days of PEF measurements both in the first and the second week, 61 (9 4%) were abnormal in the first week, 68 (10 5%) in the second week, and 24 (3 7%) in both weeks.
LONG TERM REPRODUCIBILITY
The correlation of average amplitude as a percentage of mean between the study years was low (fig 2) regardless of the time period used to calculate average amplitude as a percentage of mean (r = 0-2 for first year v first week of second year; r = 0-15 for first year v second week of second year; r = 0-2 for first year v first and second week of second year). When calculated for various subgroups (see above) the associations did not improve (data not shown), indicating that a major change in the 
ASSOCIATION WITH HEALTH VARIABLES
The associations between health variables and PEF variability were similar in the first survey and the first week of the second survey, but somewhat weaker in the second week of the second survey (table 2) . Sensitivity (specificity) of the test for a diagnosis of asthma (12 month There were only two non-atopic children with asthma (one with increased PEF variability in the first year) and four non-atopic children with recurrent wheezy bronchitis. These numbers are too small to investigate whether the association between increased PEF variability and asthma differs between atopic and nonatopic children with asthma, but our data do not suggest that there would be a difference. Stratification for asthma showed that atopy was not associated with increased PEF variability in the absence of asthma, and only weakly associated with atopy among the asthmatic children.
There was no tendency for an influence of sex on the prevalence of increased average amplitude as a percentage of mean. Children with increased PEF variability had an increased risk of developing respiratory symptoms (at least one of the four symptoms) in the subsequent year (adjusted for respiratory symptom status in the previous survey) compared with children with normal PEF variability. The adjusted odds ratios for developing respiratory symptoms in the subsequent year were 1-9 (CI 1 1 to 3-1, p<002) for the first survey and 2-8 (CI 1-6 to 4 9; p<0-001) for the second survey.
Discussion
Assessment ofvariability ofPEF by home measurements using the mini Wright peak flow meter has been proposed as an attractive tool to study the prevalence of asthma in children. It requires simple equipment, is well tolerated by children, and it has been shown that PEF variability is closely associated with non-specific bronchial hyperresponsiveness as assessed by histamine challenge."2 We observed a similar relationship between doctor diagnosed asthma and PEF variability on the one hand, and recurrent wheezy bronchitis and PEF variability on the other, supporting the view that recurrent wheezy bronchitis and asthma are both part of a single disease spectrum. Quackenboss et al studied a sample of adults and 208 children (6-15 years) in whom PEF recordings were performed four times a day over two weeks.3
They reported a sensitivity of amplitude as percentage of mean to detect asthma of 60% but a specificity of 76.8%. In our study the sensitivity was 39% in the first survey.
The children used in our study were derived from a longitudinal study. They had participated in an exercise test prior to the PEF study and were used to the peak flow meter. '5 Moreover, household visits were performed more often in better educated families who were more interested in the study. We therefore assume that our differing results are not based merely on poor compliance. Reasons for the differences in our findings compared with those of Quackenboss et al may relate to their use of four times daily measurements, a cutoff point that yielded a high sensitivity but low specificity, and a different population studied (asthma prevalence of about 20% compared with 2-5% in our study). Our study shows that there are limitations to the method which can be classified into several components: (1) decreasing compliance with longer measurement periods thus introducing measurement error (particularly in an unselected sample of healthy children); (2) biological variability of bronchial hyperresponsiveness; and (3) biological meaning of increased PEF variability which may differ from other surrogates used to estimate the degree of bronchial hyperresponsiveness.
Measurement error can be introduced by a decreasing compliance over the study period. In our study more missing values occurred in the second week and there was a tendency for the test to be performed less well in the second week. Consequently, an extension of the measurement period did not increase the qualities of the test if the aim was to use assessment of PEF variability as an asthma screening test in a healthy paediatric population. Additionally, PEF in children has been shown to be a parameter which is less reproducible than, for example, FEV,. Strachan 
